AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 4 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 27- Open
- $40.13
- 52-wk high
- $49.70
- High
- $40.38
- 52-wk low
- $39.73
- Low
- $39.73
- Prev close
- $40.20
- Mkt cap
- $41.56B
- P/E
- 14.8x
- Volume
- 6.91M
- Fwd P/E
- 13.7x
- Beta
- 0.39
- Div yield
- 4.08%
- P/S
- 1.6x
- P/B
- 1.4x
- Profit margin
- +11.0%
- Op margin
- +16.6%
- ROE
- +9.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EXC filings
Are insiders buying or selling Exelon Corporation (EXC) stock?
Neither. Exelon Corporation (EXC) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded EXC recently?
None. No member of Congress disclosed a EXC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EXC smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (1)
- SQ
Squarepoint
$28.6M
added
Sells/Trims (2)
- CI
Citadel
$104.1M
trimmed
- QR
Qube Research
$44.0M
sold
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in EXC right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
$0.43 expected
Revenue
No comparable estimate
Reports Nov 3, 2026, in 37 days
Estimates as of Sep 26, 2026
EPS expected
$0.76 to $0.89
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.71B | $5.41B | $7.24B | $5.97B |
| Cost of what it sold | $3.82B | $6.58B | $5.19B | $3.52B |
| Gross profit | $2.89B | -$1.17B | $2.05B | $2.45B |
| What it spent | ||||
| Other operating costs | $1.39B | -$2.35B | $443.0M | $1.47B |
| Total operating expenses | $1.39B | -$2.35B | $443.0M | $1.47B |
| What was left | ||||
| Operating profit | $1.50B | $1.18B | $1.60B | $979.0M |
| Interest on debt | $538.0M | $548.0M | $555.0M | $568.0M |
| Profit before tax | $1.03B | $722.0M | $1.12B | $495.0M |
| Tax | $155.0M | $128.0M | $200.0M | $99.0M |
| Net profit | $875.0M | $594.0M | $919.0M | $396.0M |
| EBITDA | $2.48B | $1.92B | $2.63B | $2.03B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace